Caris Life Sciences Dual Lists on NYSE Texas
Caris Life Sciences announced the dual listing of its common stock on NYSE Texas effective on June 17, further expanding its presence in the public markets. Caris' shares will continue to be listed and trade on its primary exchange, the Nasdaq, with a dual listing on the NYSE Texas under the same "CAI" ticker symbol, expected to provide additional exposure to investors, particularly within Texas and the broader U.S. market.
